咳嗽輔助設備市場－全球產業規模、佔有率、趨勢、機會和預測（按類型、按交付方式、按最終用戶、按地區和競爭細分，2020-2030 年預測）

2024 年全球咳嗽輔助設備市場價值為 29.8 億美元，預計到 2030 年將達到 45.5 億美元，預測期內的複合年成長率為 7.45%。隨著人們對呼吸健康的認知不斷提高，以及肌萎縮性脊髓側索硬化症 (ALS) 和肌肉營養不良症等慢性呼吸系統疾病的發病率不斷上升，推動了市場的發展。咳嗽輔助設備，也稱為機械充氣-排氣系統，用於幫助因神經肌肉疾病或脊髓損傷而無法有效咳嗽的患者。這些設備提供了一種清除呼吸道分泌物的非侵入性方法，可降低感染和住院風險。慢性病診斷率的提高、全球人口老化以及向居家照護的轉變是推動市場成長的主要因素。此外，設備設計的進步（例如便攜性、易用性和智慧連接功能）正在擴大其在機構和居家護理環境中的可及性和採用率。然而，高昂的設備成本以及低收入地區有限的可及性繼續挑戰市場滲透。儘管如此，對醫療基礎設施、產品創新和呼吸照護意識的持續投資預計將維持市場發展勢頭，尤其是在新興經濟體。

關鍵市場促進因素

慢性呼吸系統疾病盛行率上升

主要市場挑戰

設備成本高

主要市場趨勢

技術進步與人工智慧融合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球咳嗽輔助設備市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按類型（自動和手動）
  • 依交付方式選擇（面罩、咬嘴、轉接器）
  • 按最終使用者（醫院和診所、門診護理機構、家庭護理、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖
  • 按類型
  • 按選擇交付
  • 按最終用戶
  • 按地區

第6章：北美咳嗽輔助設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲咳嗽輔助設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區咳嗽輔助設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲咳嗽輔助設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲咳嗽輔助設備市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 併購
• 產品發布

第 13 章：競爭格局

• Koninklijke Philips NV
• Hillrom Holdings, Inc.
• Percussionaire Corp.
• Dima Italia Srl
• United Hayek Industries Inc
• McKesson Medical-Surgical Inc.
• Aetna Inc.
• International Biophysics Corporation
• PARI GmbH
• Air Liquide Medical Systems SA

第 14 章：策略建議

第15章調查會社について,免責事項

The Global Cough Assist Devices Market was valued at USD 2.98 billion in 2024 and is projected to reach USD 4.55 billion by 2030, expanding at a CAGR of 7.45% during the forecast period. The market is being driven by rising awareness around respiratory health and a growing prevalence of chronic respiratory illnesses such as ALS and muscular dystrophy. Cough assist devices, also known as mechanical insufflation-exsufflation systems, are used to assist patients who cannot cough effectively due to neuromuscular disorders or spinal cord injuries. These devices provide a non-invasive method for clearing airway secretions, reducing the risk of infections and hospitalizations. Increasing diagnosis of chronic conditions, an aging global population, and the shift toward home-based care are major factors contributing to market growth. Furthermore, advancements in device design-such as portability, ease of use, and smart connectivity features-are expanding access and adoption across both institutional and homecare settings. However, high equipment costs and limited access in lower-income regions continue to challenge market penetration. Nonetheless, ongoing investments in healthcare infrastructure, product innovation, and respiratory care awareness are expected to sustain market momentum, particularly in emerging economies.

Key Market Drivers

Rising prevalence of chronic respiratory diseases

The increasing incidence of chronic respiratory disorders is a key driver for the global cough assist devices market. Conditions such as COPD, asthma, bronchiectasis, and neuromuscular diseases-including ALS and muscular dystrophy-impair the ability to clear airway secretions. For patients with weakened respiratory muscles, natural coughing becomes ineffective, making cough assist devices vital for secretion clearance and infection prevention. Factors such as air pollution, smoking, and occupational exposures are accelerating the burden of respiratory diseases, particularly in low- and middle-income countries. The rise in global life expectancy is also contributing to a larger elderly population at higher risk for respiratory complications. As healthcare providers prioritize early diagnosis and preventative care, there is a growing emphasis on integrating cough assist devices into long-term treatment plans. These devices are increasingly recommended to improve patient outcomes, reduce hospital visits, and support quality of life for those living with chronic respiratory conditions. This trend is especially significant in the homecare segment, where long-term respiratory support is essential.

Key Market Challenges

High cost of devices

The high cost associated with cough assist devices is a major constraint for market expansion. These devices entail significant upfront investment, in addition to recurring expenses related to accessories, servicing, and user training. For many patients-particularly in developing regions-the cost barrier prevents access to these crucial respiratory support tools. Reimbursement policies for such devices remain inconsistent across markets, further exacerbating out-of-pocket expenses for users. Limited funding and insurance coverage often discourage healthcare professionals from prescribing these devices, knowing that affordability may be an issue for patients. In homecare settings, this financial burden typically falls on families or caregivers, creating additional reluctance to invest in the technology. While innovations in design and features continue, they often raise production costs, which manufacturers then pass on to consumers. This pricing dynamic complicates efforts to scale adoption. Solutions such as expanded reimbursement, targeted subsidies, and the development of more affordable alternatives are needed to overcome this barrier and enhance access to life-improving respiratory devices.

Key Market Trends

Technological Advancements and AI Integration

The market is being reshaped by technological advancements and the integration of artificial intelligence (AI) into cough assist devices. Newer models feature compact, portable designs, improved pressure modulation, and user-friendly interfaces that make them more comfortable and efficient for daily use. AI-powered functionalities allow these devices to analyze cough patterns and respiratory metrics, aiding in the early diagnosis and monitoring of conditions like COPD and pneumonia. Real-time data collection and predictive analytics enable more precise, individualized treatment planning. Furthermore, smart connectivity features allow remote monitoring by healthcare professionals, enhancing continuity of care and minimizing hospital visits. These innovations are particularly beneficial in homecare environments, where constant clinical supervision is not feasible. Digital platforms also foster better communication among patients, caregivers, and medical teams, contributing to improved compliance and outcomes. As AI and smart features become more widespread, cough assist devices are expected to become increasingly personalized, adaptable, and aligned with the broader trend toward connected health ecosystems.

Key Market Players

• Koninklijke Philips N.V.
• Hillrom Holdings, Inc.
• Percussionaire Corp.
• Dima Italia Srl
• United Hayek Industries Inc
• McKesson Medical-Surgical Inc.
• Aetna Inc.
• International Biophysics Corporation
• PARI GmbH
• Air Liquide Medical Systems S.A.

Report Scope:

In this report, the Global Cough Assist Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cough Assist Devices Market, By Type:

• Automatic
• Manual

Cough Assist Devices Market, By Choice of Deliver:

• Face Mask
• Mouthpiece
• Adapter

Cough Assist Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Settings
• Homecare
• Others

Cough Assist Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cough Assist Devices Market.

Available Customizations:

Global Cough Assist Devices Market report with the given Market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional Market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cough Assist Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Automatic v/s Manual)
  • 5.2.2. By Choice of Delivery (Face Mask, Mouthpiece, Adapter)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Settings, Homecare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Choice of Delivery
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Cough Assist Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Choice of Delivery
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cough Assist Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Choice of Delivery
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Cough Assist Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Choice of Delivery
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Cough Assist Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Choice of Delivery
      • 6.3.3.2.3. By End User

7. Europe Cough Assist Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Choice of Delivery
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cough Assist Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Choice of Delivery
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Cough Assist Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Choice of Delivery
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Cough Assist Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Choice of Delivery
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Cough Assist Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Choice of Delivery
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Cough Assist Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Choice of Delivery
      • 7.3.5.2.3. By End User

8. Asia-Pacific Cough Assist Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Choice of Delivery
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cough Assist Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Choice of Delivery
      • 8.3.1.2.3. By End User
  • 8.3.2. India Cough Assist Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Choice of Delivery
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Cough Assist Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Choice of Delivery
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Cough Assist Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Choice of Delivery
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Cough Assist Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Choice of Delivery
      • 8.3.5.2.3. By End User

9. South America Cough Assist Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Choice of Delivery
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cough Assist Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Choice of Delivery
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Cough Assist Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Choice of Delivery
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Cough Assist Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Choice of Delivery
      • 9.3.3.2.3. By End User

10. Middle East and Africa Cough Assist Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Choice of Delivery
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cough Assist Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Choice of Delivery
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Cough Assist Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Choice of Delivery
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Cough Assist Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Choice of Delivery
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Koninklijke Philips N.V.
  • 13.1.1. Business Overview
  • 13.1.2. Company Snapshot
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Recent Developments
  • 13.1.6. SWOT Analysis
• 13.2. Hillrom Holdings, Inc.
• 13.3. Percussionaire Corp.
• 13.4. Dima Italia Srl
• 13.5. United Hayek Industries Inc
• 13.6. McKesson Medical-Surgical Inc.
• 13.7. Aetna Inc.
• 13.8. International Biophysics Corporation
• 13.9. PARI GmbH
• 13.10. Air Liquide Medical Systems S.A.

14. Strategic Recommendations

15. About Us & DIsclaimer